Bangladesh vs Philippines: Average cost of tuberculosis treatment by type
Bangladesh
11 constant 2022 US$
in 2024
Philippines
10 constant 2022 US$
in 2024
Bangladesh rank
48th
Philippines rank
50th
Average cost of tuberculosis treatment by type over time
- Bangladesh
- Philippines
How they compare
Bangladesh currently reports 11 constant 2022 US$ against 10 constant 2022 US$ in Philippines, a difference of 1 constant 2022 US$.
That makes Bangladesh's figure about 1.1 times Philippines's.
The two have swapped places 3 times across 5 shared years of data; in 2019 it was Philippines ahead.
Bangladesh ranks 48th and Philippines ranks 50th of 62 countries.
Philippines has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bangladesh | Philippines | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 4 constant 2022 US$ | 5 constant 2022 US$ | 1 constant 2022 US$ | Philippines |
| 2020s | 14 constant 2022 US$ | 338,996 constant 2022 US$ | 338,982 constant 2022 US$ | Philippines |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of tuberculosis treatment by type, Bangladesh or Philippines?
- Bangladesh, at 11 constant 2022 US$ against 10 constant 2022 US$ in Philippines as of 2024.
- What is the difference in average cost of tuberculosis treatment by type between Bangladesh and Philippines?
- 1 constant 2022 US$, with Bangladesh ahead.
- How many years of comparable data are there for Bangladesh and Philippines?
- 5 years are reported by both, from 2019 to 2024.
- How do Bangladesh and Philippines rank globally for average cost of tuberculosis treatment by type?
- Bangladesh ranks 48th and Philippines ranks 50th of 62 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of tuberculosis treatment by type. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per person starting tuberculosis preventive treatment, excluding buffer stock.